A Phase II Trial of Gemcitabine, 5-Fluorouracil and Leucovorin in Advanced Esophageal Carcinoma

Publisher： Karger

E-ISSN： 1423-0232|69|2|130-134

ISSN： 0030-2414

Source： Oncology, Vol.69, Iss.2, 2005-09, pp. : 130-134

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Two Consecutive Phase II Studies of 5-Fluorouracil/Leucovorin/Mitomycin C and of Gemcitabine in Patients with Advanced Biliary Cancer

By  

Oncology, Vol. 56, Iss. 3, 1999-04 ,pp. : 177-180

Karger

Access to resources Recommend Favorite

A Phase II Trial of Irinotecan, 5-Fluorouracil and Leucovorin Combined with Celecoxib and Glutamine as First-Line Therapy for Advanced Colorectal Cancer

By  

Oncology, Vol. 69, Iss. 1, 2005-09 ,pp. : 63-70

Karger

Access to resources Recommend Favorite

Phase II Study of Bolus 5-Fluorouracil and Leucovorin Combined with Weekly Paclitaxel as First-Line Therapy for Advanced Gastric Cancer

By  

Oncology, Vol. 81, Iss. 5-6, 2011-11 ,pp. : 291-297

Karger

Access to resources Recommend Favorite

A Phase II Study of Infusional 5-Fluorouracil and Low-Dose Leucovorin with Docetaxel for Advanced Gastric Cancer

By  

Oncology, Vol. 70, Iss. 1, 2006-03 ,pp. : 63-70

Karger

Access to resources Recommend Favorite

Mitomycin C, 5-Fluorouracil, Leucovorin, and Oxaliplatin as a Salvage Therapy for Patients with Cisplatin-Resistant Advanced Gastric Cancer: A Phase I Dose Escalation Trial

By  

Oncology Research and Treatment, Vol. 30, Iss. 1-2, 2007-01 ,pp. : 29-34

Karger

Access to resources Recommend Favorite